Ignorance is not bliss

Although the biotech industry reacts attentively to the financial community's changing moods, ultimately it may be Main Street, not Wall Street, that determines important aspects of the industry's future.

As biotechnology products move to the marketplace, society will be forced to make serious choices about issues related to genetic testing and privacy, as well as ethical quandaries posed by the potential to intervene in the development of genetic diseases in the fetus, and the possibility of genetic therapies that "enhance" human performance...